[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Terlecki-Zaniewicz et al., 2020 - Google Patents

Biomolecular Condensation Drives Leukemia Caused by NUP98-Fusion Proteins

Terlecki-Zaniewicz et al., 2020

View HTML
Document ID
9817759094296843231
Author
Terlecki-Zaniewicz S
Eder T
Schmöllerl J
Humer T
Kuchynka N
Parapatics K
Heyes E
Liberante F
Müller A
Grebien F
Publication year
Publication venue
bioRxiv

External Links

Snippet

NUP98-fusion proteins cause acute myeloid leukemia via unknown molecular mechanisms. All NUP98-fusion proteins share an intrinsically disordered region (IDR) featuring> 35 repeats of Phenylalanine-Glycine (FG) in the NUP98 N-terminus. Conversely, different C …
Continue reading at www.biorxiv.org (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures

Similar Documents

Publication Publication Date Title
Terlecki-Zaniewicz et al. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression
Ahn et al. Phase separation drives aberrant chromatin looping and cancer development
Bertero et al. The SMAD2/3 interactome reveals that TGFβ controls m6A mRNA methylation in pluripotency
Mayor-Ruiz et al. Rational discovery of molecular glue degraders via scalable chemical profiling
Fan et al. Pervasive translation of circular RNAs driven by short IRES-like elements
Torres-Méndez et al. A novel protein domain in an ancestral splicing factor drove the evolution of neural microexons
Brown et al. Structures of translationally inactive mammalian ribosomes
Leonetti et al. A scalable strategy for high-throughput GFP tagging of endogenous human proteins
Schopp et al. Split-BioID a conditional proteomics approach to monitor the composition of spatiotemporally defined protein complexes
Marcon et al. Assessment of a method to characterize antibody selectivity and specificity for use in immunoprecipitation
Go et al. A proximity biotinylation map of a human cell
Cox et al. Sox2 uses multiple domains to associate with proteins present in Sox2-protein complexes
Li et al. CBRPP: a new RNA-centric method to study RNA–protein interactions
Tabar et al. Illuminating the dark protein-protein interactome
Rampler et al. Comprehensive cross-linking mass spectrometry reveals parallel orientation and flexible conformations of plant HOP2–MND1
Sunkel et al. Evidence of pioneer factor activity of an oncogenic fusion transcription factor
Dybkov et al. Regulation of 3′ splice site selection after step 1 of splicing by spliceosomal C* proteins
Popovic et al. Co-translational targeting of transcripts to endosomes
Lai et al. A ChIP-exo screen of 887 Protein Capture Reagents Program transcription factor antibodies in human cells
Byron et al. Characterisation of a nucleo-adhesome
Veggiani et al. High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression
Mondal et al. PROBER identifies proteins associated with programmable sequence-specific DNA in living cells
Li et al. Discovering the Interactions between Circular RNAs and RNA-binding Proteins from CLIP-seq Data using circScan
Mukhopadyay et al. A ubiquitin-specific, proximity-based labeling approach for the identification of ubiquitin ligase substrates
Gawriyski et al. Interaction network of human early embryonic transcription factors